期刊文献+

羟基喜树碱注射液两种给药方式在小鼠体内的药代动力学研究 被引量:3

Pharmacokinetics of Hydroxycamptothecin Injection in Rats
下载PDF
导出
摘要 目的:研究10-羟基喜树碱注射液在小鼠体内的药动学特征。方法:建立测定小鼠血浆中10-羟基喜树碱内酯形式的HPLC-荧光检测法.小鼠尾静脉注射和腹腔注射后不同时间点进行眼眶静脉丛取血,测定血浆中内酯形式的血药浓度,并用PKBP-N1药动学程序对血药浓度进行处理。结果:10-羟基喜树碱内酯形式可与血浆中的其它成分较好地分离,在1.25~2500ng·ml^(-1)的血药浓度范围内呈良好的线性关系,10-羟基喜树碱两种给药方式在小鼠体内的药动学特征基本相似。结论:与静脉注射给药方式比较,腹腔注射可以提高局部组织的药物浓度.减轻药物对全身的副作用。 Objective: To study the pharmacokinetic characteristics of, 10- hydroxycamptothecin(HCPT) injections in rats.Methods: A reversed-phase high-performance liquid chromatography with fluorescence detection was developed and validated for analysis of HCPT in lactone in rat plasma. The plasma concentrations of HCPT in lactone was detected at various times roll,ring a single iv and a single ip dose of 6mg/kg HCPT. The data were processed with the pharmacokinetic software PKBP- N1 .Results: A good separation of HCPT in lactone forms with other substances in plasma was obtained. The assay was liner over the range of 1.25 - 2500ng·ml^-1. There was no significant difference of pharrnacokinetic characteristics in rats between two ways. Conclusion: Compared with iv , ip can greatly increase drug concentration in tissues, decrease side effects.
出处 《黑龙江医药》 CAS 2008年第6期17-20,共4页 Heilongjiang Medicine journal
关键词 羟基喜树碱 腹腔注射 静脉注射 药劝学 10 - hydroxycamptothecin pharmacokinetics iv ip
  • 相关文献

参考文献5

二级参考文献22

  • 1吴玉波,张永恒,孙世忠,马玉艳,于千,刘旭光.喜树碱精氨酸盐静脉乳剂药物动力学及组织分布的研究[J].中国医院药学杂志,1994,14(9):406-408. 被引量:5
  • 2中国科学院上海药物研究所.10-羟基喜树碱抗癌作用的研究[J].中华医学杂志,1978,10:598-598.
  • 3王羲明.羟基喜树碱的抗癌机理和临床应用[J].中国肿瘤临床,1997,7.
  • 4-.-[J].国家基本药物,1996,:28-28.
  • 5-.湖北省药品标准(1993版)[M].,1993.553.
  • 6Zhang R,Li Y,Cai Q,et al.Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin,an inhibitor of topoisomerase I[J]. Cancer Chemother Pharmacol,1998,41(4):257-267.
  • 7Hatefi A,Amsden B. Camptothecin delivery methods[J]. Pharm Res,2002,19(10):1389-1399.
  • 8Shenderova A,Burke TG,Schwendeman SP. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins[J]. Pharm Res,1999,16(2):241-248.
  • 9Chow DS,Gong L,Wolfe MD,et al. Modified lactone/carboxylate salt equilibria in vivo by liposomal delivery of 9-nitro-camptothecin[J]. Ann N Y Acad Sci,2000,922:164-174.
  • 10Tardi P,Choice E,Masin D,et al.Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models[J]. Cancer Res,2000,60(13):3389-3393.

共引文献613

同被引文献59

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部